<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04854551</url>
  </required_header>
  <id_info>
    <org_study_id>21-2886</org_study_id>
    <nct_id>NCT04854551</nct_id>
  </id_info>
  <brief_title>Opioid Modulation and Neural Reward Activation in Healthy Adults</brief_title>
  <official_title>Opioid Modulation and Neural Reward Activation in Healthy Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a double blind study of the effects of opioid antagonism on the brain's reward&#xD;
      response. The investigators will recruit participants to undergo two scans, one on active&#xD;
      medication and one on placebo. During the scan, the investigators will assess reward.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will employ a crossover design. The study will use the monetary incentive delay&#xD;
      task during functional MRI to assess reward. This task presents participants with cues&#xD;
      indicating whether they are playing to win $5, win $0, or to avoid losing $5. This task has&#xD;
      been well-validated to elicit activation in a key reward response area of the brain called&#xD;
      the ventral striatum.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 1, 2021</start_date>
  <completion_date type="Anticipated">April 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2022</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Participants will be counterbalanced for the order they undergo placebo and medication.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>capsule, double blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Brain activation to reward</measure>
    <time_frame>one week</time_frame>
    <description>Percent signal change relative to baseline in the nucleus accumbens during cue to win $5 as assessed during functional MRI. Higher values of percent signal change indicate greater activation to reward.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Alcohol value</measure>
    <time_frame>one week</time_frame>
    <description>Maximum alcohol expenditure, or Omax, is the maximum amount of money that a person will pay for alcohol in a hypothetical alcohol consumption task called the &quot;Alcohol Purchase Task&quot;. Higher values of Omax indicate that a person values consuming alcohol at a greater level.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brain activation to emotion regulation</measure>
    <time_frame>one week</time_frame>
    <description>Percent signal change from baseline in the amygdala during trials to regulate emotion relative to trials to passively experience emotion during a functional MRI scan. Cues will be negative images, and instructions will be either &quot;decrease&quot; or &quot;look&quot;.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Alcohol Drinking</condition>
  <condition>Opioid Use, Unspecified</condition>
  <arm_group>
    <arm_group_label>Healthy adults: placebo first</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This arm will receive placebo first, then active medication second</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy adults: active medication first</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This arm will receive active medication first, then placebo second</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Naltrexone</intervention_name>
    <description>Naltrexone is an opioid antagonist with primary action at the mu opioid receptor.</description>
    <arm_group_label>Healthy adults: active medication first</arm_group_label>
    <arm_group_label>Healthy adults: placebo first</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo will be used to control for expectancy effects</description>
    <arm_group_label>Healthy adults: active medication first</arm_group_label>
    <arm_group_label>Healthy adults: placebo first</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Between 18 and 35 years of age,&#xD;
&#xD;
          -  Is a moderate drinker (i.e. consumes 1-14 drinks/week for males, or 1-7 drinks/week&#xD;
             for females).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Non-drinker&#xD;
&#xD;
          -  Positive result on urine drug screen or breathalyzer at the start of any study visit&#xD;
&#xD;
          -  Inability to complete MRI (e.g. presence of ferromagnetic objects in body)&#xD;
&#xD;
          -  Current use of medications that alter the hemodynamic response such as insulin&#xD;
&#xD;
          -  History of trauma resulting in loss of consciousness longer than 15 minutes&#xD;
&#xD;
          -  Currently taking opioid medications&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Colorado Anschutz Medical Campus</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>April 8, 2021</study_first_submitted>
  <study_first_submitted_qc>April 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 22, 2021</study_first_posted>
  <last_update_submitted>May 18, 2021</last_update_submitted>
  <last_update_submitted_qc>May 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alcohol Drinking</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Naltrexone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>The investigators would either upload to an online repository or share directly with individuals wishing to access it.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

